Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy

  • Giuseppe Tarantini
  • , Luca Nai Fovino
  • , Paola Tellaroli
  • , Alaide Chieffo
  • , Alberto Barioli
  • , Alberto Menozzi
  • , Arian Frasheri
  • , Roberto Garbo
  • , Monica Masotti-Centol
  • , Neus Salvatella
  • , Juan Francisco Oteo Dominguez
  • , Luigi Steffanon
  • , Patrizia Presbitero
  • , Edoardo Pucci
  • , Chiara Fraccaro
  • , Josepa Mauri
  • , Gennaro Giustino
  • , Gennaro Sardella
  • , Antonio Colombo

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience